We revise down our target price from VND27,100 to VND20,180 and maintain our MARKET PERFORM rating. TCM disappointed in H1 2016 with a 42% earnings decline vs H1 2015. However, the shares are now trading at a reasonable valuation after falling 25% since May 30.